Paraoxonase 192 Gln → Arg polymorphism: An independent risk factor for nonfatal arterial ischemic stroke among young adults

Stroke

Volumn 33, Issue 6, 2002, Pages 1459-1464

  Voetsch, Barbara ^a,b   Benke, Kelly S ^a   Damasceno, Benito P ^b   Siqueira, Lcia H ^b   Loscalzo, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Atherosclerosis; Polymorphism; Risk factors; Stroke, ischemic; Young adults

Indexed keywords

ARGININE; ARYLDIALKYLPHOSPHATASE; GLUTAMINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; THROMBOSIS;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ARTERIES; ARYLDIALKYLPHOSPHATASE; BRAIN ISCHEMIA; BRAZIL; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; ESTERASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 0036278052     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000016928.60995.BD     Document Type: Article

References (35)

1. Cerebral infarction in young adults: The Baltimore-Washington cooperative young stroke study
2. Stroke in the young: Incidence and pattern in Benghazi, Libya
3. Stroke in young adults in the community-based L'Aquila registry: Incidence and prognosis
4. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
5. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase
6. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
7. Protective effect of high density lipoprotein associated paraoxonase: Inhibition of the biological activity of minimally oxidized low density lipoprotein
8. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
9. Serum paraoxonase after myocardial infarction
10. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus
11. The molecular basis of the human serum paraoxonase activity polymorphism
12. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme: A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes
13. Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype?
14. Mutations in the human paraoxonasel gene: Frequencies, allelic linkages, and association with coronary artery disease
15. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease
16. Paraoxonase PON1 polymorphism Leu-Met54 is associated with carotid atherosclerosis: Results of the Austrian Stroke Prevention Study
17. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia
18. Paraoxonasel 192 Gln/Arg gene polymorphism and cerebrovascular disease: Interaction with type 2 diabetes
19. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men
20. The paraoxonase glutamine/arginine polymorphism and cerebrovascular disease
21. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases
22. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease
23. The Gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients
24. Mutation in blood coagulation factor V associated with resistance to activated protein C
25. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
26. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
27. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project: An ecological study of 18 populations
28. Field of needs: The genetics of stroke
29. Stroke in young adults: Progress and opportunities
30. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high-density lipoprotein against low-density lipoprotein oxidative modification
31. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: Three-year follow-up of the Austrian Stroke Prevention Study
32. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease
33. Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: Prospective nested case control study
34. Differential effects of smoking on myocardial infarction risk according to the Gln/Arg192 variants of the human paraoxonase gene
35. Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction